twit 25   linkedin 25

17 / Mar 01

NewCap accompanied the three Health-sector IPOs in Q1 2017

Lysogene, a biotechnology company specializing in gene therapy targeting two rare CNS diseases, raises €22.6 million in a successful initial public offering on Euronext Paris
 
Inventiva, a biopharmaceutical company developing innovative therapies, particularly to treat fibrosis, raises €48 million in a successful initial public offering on Euronext Paris
 
Symetis, a medical technology company specializing in the development, manufacturing and marketing of percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions, announced that it has agreed to be acquired by Boston Scientific for $435 million in an all cash, up-front payment.

About NewCap

As a specialist in investor relations and strategic communication advice, NewCap advises and supports its clients regarding their sectoral, scientific, institutional and financial communication strategies.

CONTACT

contact 01Address :
21, place de la Madeleine - 75008 Paris

contact 02Phone :
+33 (0)1 44 71 94 94

contact 03Email :
infos(at)newcap.fr